Phase I Cancer Investigator - Academic Leader

Rutgers University; New Brunswick (NJ); On-site; USD 283,000 - 345,000; Full time

Benefits offered by this job

Medical/dental coverage

Paid vacation & leave

Retirement benefits

Educational benefits

Life insurance

Employee discounts

Job summary

Rutgers Cancer Institute and RWJBarnabas Health seek an academically oriented medical oncologist or hematologist to lead Phase I Experimental Therapeutics. The role emphasizes design, conduct, and expansion of early‑phase trials within New Jersey’s premier cancer center, with 0.6 clinical FTE commitment and a site at the Morris Cancer Center.

The candidate will contribute to translational research, maintain a disease‑specific practice as aligned with interests, and collaborate across sponsors,

Qualifications

• MD or equivalent degree required.
• Completed or currently completing a hematology/oncology fellowship.
• Board Certified or Board Eligible in Medical Oncology and/or Hematology.
• Eligible for New Jersey medical license.
• Demonstrated interest and experience in clinical research.

Responsibilities

• Design, conduct, and expand early‑phase clinical trials (Phase I).
• Ensure protocol adherence to ICH-GCP, FDA regulations, IRB, and SOPs.
• Author and review protocols, consent forms, abstracts, and manuscripts.
• Interpret PK/PD and biomarker data to guide clinical decisions.
• Collaborate with sponsors, CROs, translational scientists, pharmacists, and coordinators.
• Assist in feasibility, site selection, and network expansion.
• Mentor students, fellows, and research staff.
• Provide startup support and research infrastructure for trial development.

Skills

Clinical research experience

Phase I trial experience

Education

MD or equivalent degree

Hematology/Oncology fellowship

Board Certified or Board Eligible in Medical Oncology and/or Hematology

Job description

Rutgers Cancer Institute and RWJBarnabas Health seek an academically oriented medical oncologist or hematologist to lead Phase I Experimental Therapeutics. The role emphasizes design, conduct, and expansion of early‑phase trials within New Jersey’s premier cancer center, with 0.6 clinical FTE commitment and a site at the Morris Cancer Center.

The candidate will contribute to translational research, maintain a disease‑specific practice as aligned with interests, and collaborate across sponsors,